Because, we also observed that CK2 inhibition improved axon function recovery by decreasing the inactivation of GSK3β in WM, these findings suggest that GSK3β could be a common target to protect both GM and WM after ischemic stroke. This evidence concerns the gene GSK3B and ischemic stroke.